Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation

Affiliations

• ¹ Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
• ² Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.
• ³ Department of Hematology, Wroclaw Medical University, Wroclaw, Poland.
• ⁴ Mathematical Oncology Unit, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.